Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Directorate Change

16 Oct 2019 16:11

RNS Number : 1333Q
Cenkos Securities PLC
16 October 2019
 

16 October 2019

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation EU 596/2014 ("MAR").

 

 

Cenkos Securities plc

("Cenkos" or the "Company")

 

Directorate Change

 

The Board of Cenkos is pleased to announce the appointment of Julian Morse, as an Executive Director of the Company. This appointment is subject to Financial Conduct Authority approval and will take effect on the receipt of regulatory consent.

 

Julian is Head of the Cenkos Growth Companies Team and has led that team since 2016. He is one of the founding members of the team having joined Cenkos in 2006. He has over 25 years' experience in the City where he has advised and raised equity on IPO's and secondary fund raisings for a wide range of companies across a broad range of sectors. Previously, Julian was a Director at Beeson Gregory and Evolution Securities.

Commenting on the appointment, Jeff Hewitt Acting Chairman of the Company, said:

"I am delighted that Julian has agreed to join the Board. With Julian's experience and proven success in managing the Growth Companies team he will provide a valuable addition to the Board and will assist in driving the whole business forward."

Additional Information

 

In accordance with the AIM Rules, the following information is required to be disclosed in relation to Julian Morse is set out below. Other than this information, there is no further information required to be disclosed under paragraph (g) of Schedule Two of the AIM Rules.

 

Full Name and age:

Julian Jonathan Morse aged 48

 

Current Directorships/Partnerships:

None

 

Previous Directorships/Partnerships:

Dovemoat LLP - LLP member resigned 17 November 2015

 

Current interest in the Company's share capital:

403,239 Ordinary shares of 1 pence held under his Self-Invested Personal Pension

384,501 Ordinary shares of 1 pence held in accordance with the terms and conditions of Company's Deferred Bonus Scheme

18,842 Ordinary shares of 1 pence shares held in the Company's Share Incentive Plan of which X are subject to forfeiture

 

Options over 185,220 Ordinary shares held under the Compensatory Award Plan Options. These options are at 169.0 pence. These options expire on 22 October 2019.

 

Options over 21,094 Ordinary shares held under the Company's Save As You Earn Plan. These options are at 85.3 pence. These options expire on 30 November 2021.

 

 

 

 

Enquiries:

 

Cenkos Securities plc

Jim Durkin, Chief Executive Officer

 

Tel: 0207 397 8900

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser

 

Tel: 0203 368 3552

Whitman Howard Limited

Nick Lovering, Broker

 

Tel: 0207 659 1224

Buchanan Communications

David Rydell, PR Adviser

Tel: 0207 466 5066

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABUBDGRGBBGCL
Date   Source Headline
15th Apr 20199:48 amRNSForm 8.5 (EPT/NON-RI)
12th Apr 201911:05 amRNSForm 8.5 (EPT/NON-RI)
11th Apr 20199:57 amRNSForm 8.5 (EPT/NON-RI)
10th Apr 201912:36 pmRNSPDMR Shareholding
10th Apr 201912:35 pmRNSEBT Share Transfer
8th Apr 20195:05 pmRNSEBT Share Purchase
5th Apr 20192:30 pmRNSEBT Share Purchase
5th Apr 20191:57 pmRNSAnnual Report and Annual General Meeting Notice
2nd Apr 201912:27 pmRNSEBT Share Purchase
1st Apr 201912:08 pmRNSEBT Share Purchase
1st Apr 201910:16 amRNSDirectorate Changes
26th Mar 201912:33 pmRNSDirector/PDMR Shareholding
26th Mar 20197:00 amRNSAnnual Results for the year ended 31 December 2018
13th Mar 201910:54 amRNSEBT Share Purchase
11th Mar 20197:00 amRNSDirectorate Change
19th Feb 20191:05 pmRNSEBT Share Purchase
7th Feb 201910:19 amRNSEBT Share Purchase
29th Jan 201910:08 amRNSEBT Share Purchase
28th Jan 201911:11 amRNSEBT Share Purchase
25th Jan 201910:44 amRNSEBT Share Purchase
23rd Jan 20194:14 pmRNSEBT Share Purchase Plan
19th Dec 20183:50 pmRNSTrading Update
12th Dec 20183:56 pmRNSEBT Share Purchase
12th Dec 20187:45 amRNSAcquisition of Business
12th Dec 20187:00 amRNSDirectorate Changes
28th Nov 20184:09 pmRNSEBT Share Purchase
28th Nov 201810:00 amRNSPDMR Shareholding
7th Nov 201810:35 amRNSEBT Share Purchase
6th Nov 20185:10 pmRNSAward of shares under SIP and Directors' Dealings
6th Nov 20181:33 pmRNSEBT Share Purchase
5th Nov 20187:00 amRNSBoard Changes
31st Oct 20184:29 pmRNSBoard Change
16th Oct 20185:14 pmRNSBlock listing Interim Review
9th Oct 20187:00 amRNSBoard Change
3rd Oct 201810:02 amRNSEBT Share Purchase
18th Sep 20187:00 amRNSInterim Results for six months ended 30 June 2018
10th Sep 201812:00 pmRNSEBT Share Purchase
7th Sep 201810:19 amRNSEBT Share Purchase
16th Aug 201812:19 pmRNSEBT Share Purchase
6th Aug 201812:02 pmRNSEBT Share Purchase
1st Aug 20187:00 amRNSAcquisition of business
24th Jul 201811:06 amRNSSecond Price Monitoring Extn
24th Jul 201811:00 amRNSPrice Monitoring Extension
24th Jul 20187:00 amRNSTrading Update
23rd Jul 20185:33 pmRNSEBT Share Purchase
20th Jul 20187:00 amRNSChange of Adviser
3rd Jul 20189:02 amRNSForm 8.5 (EPT/NON-RI)
2nd Jul 20189:47 amRNSForm 8.5 (EPT/NON-RI)
29th Jun 201810:31 amRNSForm 8.5 (EPT/NON-RI)
25th Jun 201811:50 amRNSEBT Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.